Zimmer Biomet Holdings Return on Investment 2006-2020 | ZBH
Current and historical return on investment (ROI) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Zimmer Biomet Holdings ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2020-03-31 | $0.33B | $19.61B | 1.76% |
| 2019-12-31 | $1.14B | $19.11B | 6.01% |
| 2019-09-30 | $0.01B | $18.43B | 0.05% |
| 2019-06-30 | $-0.01B | $18.38B | -0.07% |
| 2019-03-31 | $0.08B | $19.85B | 0.38% |
| 2018-12-31 | $0.03B | $19.69B | 0.16% |
| 2018-09-30 | $0.78B | $20.82B | 3.71% |
| 2018-06-30 | $0.77B | $21.46B | 3.71% |
| 2018-03-31 | $0.76B | $21.49B | 3.71% |
| 2017-12-31 | $0.80B | $20.65B | 3.97% |
| 2017-09-30 | $1.02B | $19.65B | 5.08% |
| 2017-06-30 | $1.00B | $19.63B | 4.94% |
| 2017-03-31 | $0.92B | $20.47B | 4.53% |
| 2016-12-31 | $0.82B | $20.34B | 4.01% |
| 2016-09-30 | $0.86B | $20.75B | 4.13% |
| 2016-06-30 | $0.78B | $20.08B | 3.70% |
| 2016-03-31 | $0.44B | $20.78B | 2.07% |
| 2015-12-31 | $0.47B | $21.39B | 2.32% |
| 2015-09-30 | $0.48B | $21.68B | 2.83% |
| 2015-06-30 | $0.61B | $21.88B | 4.59% |
| 2015-03-31 | $1.01B | $15.64B | 10.14% |
| 2014-12-31 | $1.04B | $7.98B | 12.96% |
| 2014-09-30 | $1.16B | $7.97B | 14.55% |
| 2014-06-30 | $1.12B | $8.14B | 14.08% |
| 2014-03-31 | $1.07B | $7.92B | 13.68% |
| 2013-12-31 | $1.07B | $7.97B | 13.87% |
| 2013-09-30 | $0.92B | $7.83B | 12.12% |
| 2013-06-30 | $0.96B | $7.58B | 12.71% |
| 2013-03-31 | $1.05B | $7.42B | 14.00% |
| 2012-12-31 | $1.05B | $7.59B | 14.06% |
| 2012-09-30 | $1.05B | $7.57B | 14.29% |
| 2012-06-30 | $1.07B | $7.44B | 14.75% |
| 2012-03-31 | $1.02B | $7.23B | 14.29% |
| 2011-12-31 | $1.02B | $7.09B | 14.42% |
| 2011-09-30 | $0.95B | $7.15B | 13.40% |
| 2011-06-30 | $0.95B | $7.16B | 13.57% |
| 2011-03-31 | $0.92B | $7.01B | 13.26% |
| 2010-12-31 | $0.92B | $6.91B | 13.30% |
| 2010-09-30 | $1.03B | $6.96B | 15.06% |
| 2010-06-30 | $0.97B | $6.87B | 14.27% |
| 2010-03-31 | $1.03B | $6.84B | 15.52% |
| 2009-12-31 | $1.02B | $6.77B | 15.68% |
| 2009-09-30 | $1.02B | $6.58B | 16.10% |
| 2009-06-30 | $1.03B | $6.46B | 16.60% |
| 2009-03-31 | $1.04B | $6.22B | 17.22% |
| 2008-12-31 | $1.09B | $6.11B | 18.38% |
| 2008-09-30 | $1.20B | $5.95B | 20.76% |
| 2008-06-30 | $1.12B | $5.83B | 19.82% |
| 2008-03-31 | $1.13B | $5.82B | 20.50% |
| 2007-12-31 | $1.13B | $5.55B | 20.98% |
| 2007-09-30 | $1.11B | $5.36B | 21.25% |
| 2007-06-30 | $1.24B | $5.38B | 24.23% |
| 2007-03-31 | $1.20B | $5.22B | 23.90% |
| 2006-12-31 | $1.17B | $5.02B | 23.43% |
| 2006-09-30 | $1.11B | $4.91B | 22.57% |
| 2006-06-30 | $1.10B | $4.98B | 22.65% |
| 2006-03-31 | $1.09B | $5.01B | 23.01% |
| 2005-12-31 | $1.06B | $4.76B | 22.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.470B | $7.982B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $161.796B | 28.06 |
| Medtronic (MDT) | Ireland | $126.941B | 20.64 |
| Stryker (SYK) | United States | $69.021B | 22.40 |
| Boston Scientific (BSX) | United States | $50.251B | 23.63 |
| Baxter (BAX) | United States | $44.091B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $37.041B | 0.00 |
| Terumo (TRUMY) | Japan | $28.057B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $26.322B | 0.00 |
| ResMed (RMD) | United States | $23.342B | 36.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.880B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.213B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.007B | 63.76 |
| Insulet (PODD) | United States | $12.117B | 1200.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $7.417B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.399B | 13.24 |
| Quidel (QDEL) | United States | $7.286B | 57.26 |
| Canopy Growth (CGC) | Canada | $6.813B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.659B | 18.77 |
| GN STORE NORD (GNNDY) | Denmark | $6.590B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $6.417B | 0.00 |
| Haemonetics (HAE) | United States | $5.439B | 32.67 |
| ICU Medical (ICUI) | United States | $3.980B | 29.03 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.925B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.636B | 0.00 |
| Neogen (NEOG) | United States | $3.523B | 59.67 |
| NuVasive (NUVA) | United States | $3.220B | 25.86 |
| Envista Holdings (NVST) | United States | $3.020B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.826B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.406B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.037B | 35.24 |
| AtriCure (ATRC) | United States | $1.994B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.624B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.306B | 0.00 |
| MacroGenics (MGNX) | United States | $1.247B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.173B | 0.00 |
| Aphria (APHA) | Canada | $1.080B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.001B | 19.96 |
| Cerus (CERS) | United States | $0.971B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.923B | 185.88 |
| InMode (INMD) | Israel | $0.838B | 17.70 |
| Omeros (OMER) | United States | $0.837B | 0.00 |
| PetIQ (PETQ) | United States | $0.818B | 23.62 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.756B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.726B | 52.03 |
| VAREX IMAGING (VREX) | United States | $0.684B | 16.99 |
| Quanterix (QTRX) | United States | $0.681B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.635B | 23.92 |
| Zynex (ZYXI) | United States | $0.631B | 63.33 |
| Vapotherm (VAPO) | United States | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.505B | 60.88 |
| Lantheus Holdings (LNTH) | United States | $0.505B | 10.16 |
| LeMaitre Vascular (LMAT) | United States | $0.503B | 28.67 |
| Owens & Minor (OMI) | United States | $0.463B | 12.25 |
| Repro-Med Systems (KRMD) | United States | $0.387B | 325.00 |
| Cytosorbents (CTSO) | United States | $0.378B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.333B | 24.16 |
| BioLife Solutions (BLFS) | United States | $0.328B | 145.91 |
| Viemed Healthcare (VMD) | United States | $0.323B | 28.90 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.290B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.290B | 0.00 |
| HEXO (HEXO) | $0.256B | 0.00 | |
| Female Health (VERU) | United States | $0.241B | 0.00 |
| Chimerix (CMRX) | United States | $0.207B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.191B | 0.00 |
| Exagen (XGN) | United States | $0.175B | 0.00 |
| Bovie Medical (APYX) | United States | $0.157B | 0.00 |
| Evolus (EOLS) | United States | $0.151B | 0.00 |
| Surface Oncology (SURF) | United States | $0.148B | 0.00 |
| Fonar (FONR) | United States | $0.148B | 13.08 |
| Rockwell Medical (RMTI) | United States | $0.146B | 0.00 |
| United Health Products (UEEC) | United States | $0.134B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.131B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.119B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.119B | 0.00 |
| Brainsway (BWAY) | Israel | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.077B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.077B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.076B | 0.00 |
| Nephros (NEPH) | United States | $0.070B | 0.00 |
| United-Guardian (UG) | United States | $0.069B | 16.01 |
| GUARDION HEALTH (GHSI) | United States | $0.047B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.036B | 0.00 |
| ImmuCell (ICCC) | United States | $0.030B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.026B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.021B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.018B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
